Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An update from RaySearch Laboratories AB ( ($SE:RAY.B) ) is now available.
In the second quarter of 2025, RaySearch Laboratories AB experienced a 4.4% decrease in net sales compared to the previous year, with a notable decline in license revenue by 19.8% but an increase in support revenue by 13.9%. Despite a drop in operating profit and cash flow, the company launched significant updates to its RayStation and RayCare systems, marking advancements in treatment planning and clinical workflow efficiency. Strategic partnerships and new orders from prominent hospitals indicate a positive outlook for future growth and market positioning.
More about RaySearch Laboratories AB
RaySearch Laboratories AB is a company operating in the medical technology industry, specializing in software solutions for radiation therapy. Their primary products include the RayStation treatment planning system and RayCare oncology information system, focusing on enhancing clinical workflows and treatment planning capabilities.
Average Trading Volume: 124,286
Technical Sentiment Signal: Buy
Current Market Cap: SEK10.7B
For a thorough assessment of RAY.B stock, go to TipRanks’ Stock Analysis page.